Early Detection
438 articles
Treatments and Clinical Trials
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program cosponsored a webinar about treatments and clinical trials.
Hope is Everything You Have
Long-term survivor Eric Borden believes in the importance of advocating for yourself with your doctors; if he hadn’t he might not be here.
Chemo and SBRT for Inoperable Pancreatic Cancer
For inoperable pancreatic cancer, researchers are comparing mFOLFIRINOX and SBRT with gemcitabine-based treatment regimens.
Have Hope
Andy Seynaeve has undergone many rounds of chemotherapy but he has had a great response. Best of all, he has hope.
Early Diagnosis, Great Doctors, and Prayer
Jennifer Lambert was diagnosed with pancreatic cancer while on vacation in Spain. She returned home for a Whipple procedure and chemotherapy.
At the Table: Advocating For Yourself
Patients and survivors discuss the value of advocating for yourself during treatment, whether choosing a doctor or participating in a trial.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
Picking a Clinical Trial for Pancreatic Cancer Treatment
When Robert Weker was diagnosed with pancreatic cancer, he believed a clinical trial was his best chance of reducing the tumor enough for a Whipple.
The Importance of Family and Friends
Michael Florio has been able to count on his family and friends to get him to pancreatic cancer treatment and support him through a Whipple procedure.
Mary Fisher
The world “discovered” Mary Fisher on the evening of August 19, 1992, when she delivered a speech at the 1992 Republican Convention. It is ranked as one of the 100 greatest American speeches in the 20th Century. Since the steaming night in Houston, the world has come to know Mary as a gifted artist, a […]
A Second Opinion Leads to a New Treatment Plan
Brad Kerr changed his pancreatic cancer treatment plan after getting a second opinion, and had neoadjuvant chemotherapy before his Whipple.
Personalizing Pancreatic Cancer Treatment
Dr. Mark Ricigliano takes a closer look at the genetics of circulating tumor cells, to personalize pancreatic cancer treatment for the best results.
BRCA’s Role in Pancreatic Cancer Investigated
The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.
Precision Medicine from the Get-Go for Pancreatic Cancer
Dr. Ben George and colleagues at the Medical College of Wisconsin are using molecular profiling to determine the best chemotherapy for a patient’s pancreatic cancer.
Targeting the Undruggable KRAS Protein
Dr. Shubham Pant is focusing his research on effective treatments for the KRAS mutation, found in 90% of pancreatic cancers.